Stock GCTK GLUCOTRACK, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News GlucoTrack, Inc.

Equities

GCTK

US45824Q5071

Delayed Nasdaq
Other stock markets
 15:49:22 2024-05-15 EDT 		5-day change 1st Jan Change
0.495 USD -10.02% Intraday chart for GlucoTrack, Inc. -14.67% +89.29%
04-22 GlucoTrack, Inc. announced that it has received $0.5 million in funding CI
04-16 Glucotrack Expanding Glucose Monitoring Technology to Epidural Space MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION
AQ
GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT
AQ
Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK
AQ
GlucoTrack, Inc. announced that it has received $0.5 million in funding
CI
Glucotrack Expanding Glucose Monitoring Technology to Epidural Space
MT
GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING
AQ
GlucoTrack, Inc. Announces Expansion of its Continues Glucose Monitoring Technology to Epidural Glucose Monitoring
CI
GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR
AQ
Glucotrack Announces Increased Sensor Longevity for Its Implantable Continuous Blood Glucose Monitor
CI
GlucoTrack, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY
AQ
GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR
AQ
GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAVÉ TO CHAIR OF THE BOARD OF DIRECTORS
AQ
Glucotrack, Inc Announces Appointment of Luis Malavé as Chairman of Its Board of Directors
CI
GlucoTrack Says Implantable Glucose Monitor Safe With High Level of Accuracy; Shares Rise
MT
GlucoTrack, Inc. Announces Early Accuracy Data for its Implantable Continuous Glucose Monitor
CI
GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR
AQ
GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
AQ
GlucoTrack, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
GLUCOTRACK ANNOUNCES SHAREHOLDER UPDATE
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GCTK Stock
  4. News GlucoTrack, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW